| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/24/2007 | CA2629814A1 Bisamide inhibitors of hedgehog signaling |
| 05/23/2007 | EP1787981A1 New N-phenethylcarboxamide derivatives |
| 05/23/2007 | EP1787657A1 Therapeutic agent for psychoneurotic disease |
| 05/23/2007 | EP1786799A1 Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
| 05/23/2007 | EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists |
| 05/23/2007 | EP1786778A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/23/2007 | EP1786777A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 05/23/2007 | EP1786776A1 Method for producing high-purity quaternary ammonium compounds |
| 05/23/2007 | EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 05/23/2007 | EP1786761A1 Method for the production of tricyanomethanides of organic cations |
| 05/23/2007 | EP1562923B1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1363885B1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 05/23/2007 | EP1326993B1 Production of alpha-hydroxy-carboxylic acids using a coupled enzyme system |
| 05/23/2007 | EP1257535B1 Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | EP1238974B1 Heterocycle derivatives and drugs |
| 05/23/2007 | CN1968950A Pyridinylisoxazoles and their use as herbicides |
| 05/23/2007 | CN1968921A Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/23/2007 | CN1966503A 2,6-dimethyl-3,5-bi-(2-methyl-3-N-acetyl-5-phenyl-[1,3,4] oxadiazoles) pyridine and its synthesis method |
| 05/23/2007 | CN1966502A Functionalized picolinic acid double dentate anion ligand and its annular metal iridium complex and uses |
| 05/23/2007 | CN1966494A 2-chloro-5-chloromethyl pyridine refining method |
| 05/23/2007 | CN1966493A Amino acid derivative and its salts and solvate, its preparation method and uses |
| 05/23/2007 | CN1317275C Sulfoxide compound and complex of acetone, and production method thereof |
| 05/23/2007 | CN1317269C Method for producing 2-halogen-pyridine-carboxylic acid amides |
| 05/23/2007 | CN1317268C 2,6-dimethylpyridine preparation method |
| 05/23/2007 | CN1317265C Cyanoacrylate derivatives and their preparation method and biological activity |
| 05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
| 05/22/2007 | US7220876 Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220784 Substituted stilbenes and their reactions |
| 05/22/2007 | US7220783 Para-terphenyl compounds |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament |
| 05/22/2007 | US7220761 Compounds and methods for controlling fungi, bacteria and insects |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/22/2007 | CA2281892C Processes for preparing pesticidal intermediates |
| 05/22/2007 | CA2275353C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 05/22/2007 | CA2266050C Piperazine derivatives |
| 05/22/2007 | CA2262603C Process for preparing fluorine-containing compounds |
| 05/22/2007 | CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
| 05/22/2007 | CA2231800C Process for the preparation of 2,6-pyridinedicarboxylic acid esters |
| 05/22/2007 | CA2157146C Heterocyclyl-benzoylguanidines |
| 05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
| 05/18/2007 | WO2007056341A1 Heterocyclic modulators of atp-binding cassette transporters |
| 05/18/2007 | WO2007056151A2 Protein kinase inhbitors |
| 05/18/2007 | WO2007055183A1 Benzene derivative or salt thereof |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007023295A3 Use of grinding in chemical synthesis |
| 05/18/2007 | WO2007006387A3 Onium-alkylsulfonate production method |
| 05/18/2007 | WO2007003944A3 Compounds for imaging and therapy |
| 05/18/2007 | WO2007002635B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 05/18/2007 | WO2006099605A3 Dimeric and trimeric nucleic acid dyes, and associated systems and methods |
| 05/18/2007 | WO2006034474A3 Novel pyridine compounds, process for their preparation and compositions containing them |
| 05/18/2007 | CA2627358A1 Heterocyclic modulators of atp-binding cassette transporters |
| 05/18/2007 | CA2627086A1 Pharmaceutical salts and polymorphs of n-(5-chl0r0-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxy-benzamide, a factor xa inhibitor |
| 05/18/2007 | CA2626479A1 Protein kinase inhibitors |
| 05/17/2007 | US20070112040 Amino nicotinate derivatives as glucokinase (GLK) modulators |
| 05/17/2007 | US20070112039 Better thermal and hydrolytic stability than the free-base compounds; N-(5-chloro-pyridin-2-yl)-2-(4-cyano-benzoyl-amino)-5-methoxy-benzamide Hydrochloride |
| 05/17/2007 | US20070112038 mitogen activated protein kinase inhibitors; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals; Methyl 2-(4-bromo-2-fluorophenylamino)-5-ethyl-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate; synergistic use |
| 05/17/2007 | US20070112036 Opioid receptor antagonists |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111999 P-38 kinase inhibitors |
| 05/17/2007 | US20070110881 Astaxanthin-disuccinate and Astaxanthin dimethyldisuccinate; pigmenting carotinoids for feed for aquatic animals; improved stability during extrusion at elevated temperatures; storage stability |
| 05/16/2007 | EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 05/16/2007 | EP1784380A1 Method for high-purity quaternary ammonium compounds |
| 05/16/2007 | EP1684752B1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 05/16/2007 | EP1434485B1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives for use as pesticides |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | CN1965034A Dye and dye-sensitized solar cell |
| 05/16/2007 | CN1964946A 2-propylene-1-ones as hsp70 inducer |
| 05/16/2007 | CN1964945A Alkyl pyridinium dicyanamides and method for the production thereof |
| 05/16/2007 | CN1962655A Method for extracting nicotine from waste tobacco leaf through liquid film method |
| 05/16/2007 | CN1962644A PI3K enzyme inhibitor-5-(3-amino-benzene) methyl nicotinate analog |
| 05/16/2007 | CN1962637A Ozonization method for preparing nicotinic acid |
| 05/16/2007 | CN1962636A 2,Process for preparing 3-dimethylpyridine |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/16/2007 | CN1315805C Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins |
| 05/16/2007 | CN1315803C Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/15/2007 | US7217740 Diarylsulfones as 5-HT2A antagonists |
| 05/15/2007 | US7217736 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/15/2007 | US7217677 Such as formation of 4-octylanisole from p-methoxyphenyl boronic acid and 1-bromooctane using bis(1,5-cyclooctadiene)nickel catalyst and bis(N-methylimidazole-2-yl)methane |
| 05/15/2007 | CA2437844C Method for increasing leptin levels using nicotinic acid compounds |
| 05/10/2007 | WO2007053436A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007051847A1 Tricyclo substituted amides as glucokinase modulators |
| 05/10/2007 | WO2007051759A1 Process for the preparation of pyridylcarboxylic amides and esters |
| 05/10/2007 | WO2007025709A3 Organic compounds |
| 05/10/2007 | WO2007006591A3 Dihalogenation of n,o-disubstituted hydroxipyridones and uses thereof |
| 05/10/2007 | WO2006127205A3 Methods of preparing 3-cyano-quinolines and intermediates made thereby |
| 05/10/2007 | WO2006105076A3 Processes for preparing monomer complexes |
| 05/10/2007 | WO2002010431A3 Functional biopolymer modification reagents and uses thereof |
| 05/10/2007 | US20070106041 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution, used for separation of enantiomers, diastereomers of the template molecule, separation of template |
| 05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |